Role of miRNAs in breast cancer

Asian Pacific Journal of Cancer Prevention

Volumn 12, Issue 12, 2011, Pages 3175-3180

  ur Rehman Kayani, Masood ^a   Kayani, Mahmood Akthar ^a   Malik, Faraz Arshad ^a   Rani, Faryal ^a  

^a Comsats Institute of Information Technology ^*  (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA;

BREAST TUMOR; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; PATHOLOGY; PHYSIOLOGY; REVIEW;

BREAST NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS;

EID: 84864507103     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Aktas H, Cai H, Cooper GM, (1997). Ras links growth factor signaling to the cell cycle machinery via regulation of cyclin D1 and the Cdk inhibitor p27KIP1. Molec Cell Biol, 17, 3850-57.
2. Aprelikova ON, Fang BS, Meissner EG, et al (1999). BRCA1-associated growth arrest is RB-dependent. Proc Natl Acad Sci USA, 96, 11866-71.
3. Atalay G, Cardoso F, Awada A, et al (2003). Novel therapeutic strategies targeting the epidermal growth factor receptor (EGFR) family and its downstream effectors in breast cancer. Ann Oncol, 14, 1346-63.
4. Bhaumik D, Scott GK, Schokrpur S, et al (1998). Expression of microRNA-146 suppresses NF-?B activity with reduction of metastatic potential in breast cancer cells. Oncogene, 27, 5643-47.
5. Brown AMC, (2001). Wnt signaling in breast cancer: have we come full circle? Breast Cancer Research, 3, 351-5.
6. Burk U, Schubert J, Wellner U, et al (2008). A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. EMBO Reports, 9, 582-9.
7. Bushati N, Cohen SM, (2007). microRNA functions. Ann Rev Cell Develop Biol, 23, 175-205.
8. Calin GA, Carlo MC, (2006) Micro-RNA-cancer connection: The beginning of a new tale. Cancer Res, 66, 7390-4.
9. Caudy AA, Myers M, Hannon GJ et al (2002). Fragile X-related protein and VIG associate with the RNA. Genes Development, 16, 2491-6.
10. Cochrane DR, Howe EN, Spoelstra NS, et al (2010). Loss of miR-200c: A marker of aggressiveness and chemoresistance in female reproductive cancers. J Oncol, 2010, 821717.
11. Cummins JM, Velculescu VE, (2006). Implications of micro-RNA profiling for cancer diagnosis. Oncogene, 25, 6220-7.
12. Bartel DP, (2004). MicroRNAs: genomics, biogenesis, mechanism, and function, Cell, 116, 281-97.
13. D'Abaco GM, Hooper S, Paterson H, et al (2002). Loss of Rb overrides the requirement for ERK activity for cell proliferation. J Cell Sci, 115, 4607-16.
14. Frankel LB, Christoffersen NR, Jacobsen A, et al (2008). Programmed Cell Death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer Cells. J Biol Chem, 283, 1026-33.
15. Greer EL, and Brunet A, (2005). FOXO transcription factors at the interface between longevity and tumor suppression. Oncogene, 24, 7410-25.
16. Gubin MM, Calaluce R, Davis JW, et al (2010). Overexpression of the RNA binding protein HuR impairs tumor growth in triple negative breast cancer associated with deficient angiogenesis. Cell Cycle, 9, 3337-46.
17. Guo X, Wu Y, and Hartley RS, (2009). MicroRNA-125a represses cell growth by targeting HuR in breast cancer. RNA Biology, 6, 575-83.
18. Guttilla IK, and White BA, (2009). Coordinate regulation of FOXO1 by miR-27a, miR-96, and miR-182 in breast cancer cells. J Biol Chem, 284, 23204-16.
19. Harfe BD, (2005). MicroRNAs in vertebrate development. Curr Opin Genetics Develop, 15, 410-5.
20. He H, Jazdzewski K, Li W, et al (2005). The role of microRNA genes in papillary thyroid carcinoma. Proc Natl Acad Sci USA, 102, 19075-80.
21. Hoenerhoff MJ, Chu I, Barkan D, et al (2009). BMI1 cooperates with H-RAS to induce an aggressive breast cancer Phenotype with brain metastases. Oncogene, 28, 3022-32.
22. Hossain A, Kuo MT, and Saunders GF, (2006). Mir-17-5p regulates breast cancer cell proliferation by inhibiting translation of AIB1 mRNA. Molec Cell Biol, 26, 8191-201.
23. Hurst DR, Edmonds MD, Scott GK, et al (2009). Breast Cancer Metastasis Suppressor 1 Up-regulates miR-146, Which Suppresses Breast Cancer Metastasis. Cancer Res, 69, 1279-9.
24. Iorio MV, Ferracin M, Liu CG, et al (2005). microRNA gene expression deregulation in human breast cancer. Cancer Res, 65, 7065-70.
25. Ruby JG, Jan C, and Bartel DP, (2007). Intronic microRNA precursors that bypass Drosha processing. Nature, 448, 83-6.
26. Katou M, (2005). WNT/PCP signaling pathway and human cancer. Oncology Reports, 14, 1583-8.
27. Kovalchuk O, Filkowski J, Meservy J, et al (2008). Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin. Molecular Cancer Therapeutics, 7, 2152-9.
28. Le Sage C, Nagel R, Egan DA, et al (2007). Regulation of the p27(Kip1) tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation. EMBO J, 26, 3699-708.
29. Li M, Carpio DF, Zheng Y, et al (2001). An essential role of the NF-kB/Toll-Like receptor pathway in induction of inflammatory and tissue-repair gene expression by necrotic cells. J Immunol, 166, 7128-35.
30. Lim LP, Glasner ME, Yekta S, et al (2003). Vertebrate microRNA genes. Science, 299, 1540-9.
31. Louie MC, Zou JX, Rabinovich A, et al (2004). ACTR/AIB1 functions as an E2F1 coactivator to promote breast cancer cell proliferation and antiestrogen resistance. Molec Cell Biol, 24, 5157-71.
32. McDonnell DP, and Norris JD, (2002). Connections and regulation of the human estrogen receptor. Science, 296, 1642-4.
33. Michael MZ, O'Connor SM, Van Holst Pellekaan NG, et al (2003). Reduced accumulation of specific microRNAs in colorectal neoplasia. Molec Cancer Res, 1, 882-891.
34. Mohinta S, Wu H, Chaurasia P, et al (2007). Wnt pathway and breast cancer. Frontiers Bioscience, 12, 4020-33.
35. Pan S, Yu F, Gong C, et al (2009). Tumor invasion and metastasis initiated by mir-106b in breast cancer by targeting BRMS1 and RB. Cancer Res, 69, 6157-9.
36. Pan YZ, Morris ME, and Yu AM. (2009). MicroRNA-328 negatively regulates the expression of breast cancer resistance protein (BCRP/ABCG2) in human cancer cells. Molec Pharmacol, 75, 1374-9.
37. Park SM, Gaur AB, Lengyel E, et al (2008). The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes and Development, 22, 894-907.
38. Polakis P, (2000). Wnt signaling and cancer. Genes Develop, 14, 1837-51.
39. Ramaswamy S, Nakamura N, Vazquez F, et al (1999). Regulation of G1 progression by the PTEN tumor suppressor protein is linked to inhibition of the phosphatidylinositol 3-kinase/Akt pathway. Proc Natl Acad Sci USA, 96, 2110-5.
40. Pfeffer S, Zavolan M, Grasser FA, et al (2004). Identifi cation of virus-encoded microRNAs. Science, 304, 734-6.
41. Ying SY, and Lin SL, (2005). Intronic microRNAs. Biochem Biophys Res Commun, 326, 515-20.
42. Saeki M, Kobayashi D, Tsuji N, et al (2009). Diagnostic importance of overexpression of Bmi-1 mRNA in early breast cancers. Int J Oncol, 35, 511-5.
43. Sætrom P, Biesinger J, Li S, et al (2009). A risk variant in a miR-125b binding site in BMPR1B is associated with breast cancer pathogenesis. Cancer Res, 69, 7459-65.
44. Schmidt M, Fernandez de Mattos S, van der Horst A, et al (2002). Cell Cycle Inhibition by FoxO Forkhead Transcription Factors Involves Downregulation of Cyclin D. Molec Cell Biol, 22, 7842-52.
45. Shen J, Ambrosone CB, DiCioccio RA, et al (2008). A functional polymorphism in the miR-146a gene and age of familial breast/ovarian cancer diagnosis. Carcinogenesis, 29, 1963-6.
46. Si ML, Zhu S, Wu H, et al (2007). miR-21-mediated tumor growth Suppression of tumor growth by anti-miR-21. Oncogene, 26, 2799-803.
47. Taganov KD, Boldin MP, Chang KJ, et al (2006). NF-?B-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci USA, 103, 12481-6.
48. Takamizawa J, Konishi H, Yanagisawa K, et al (2004). Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res, 64, 3753-6.
49. Valastyan S, Reinhardt F, Benaich N, et al (2009). A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis. Cell, 137, 1032-46.
50. Lee Y, Jeon K, Lee JT, et al (2002). MicroRNA maturation: stepwise processing and subcellular localization. EMBO J, 21, 4663-70.
51. Yang MH, Hsu DSS, Wang HW, et al (2010). Bmi1 is essential in Twist1-induced epithelial-mesenchymal transition. Nature Cell Biol, 12, 982-92.
52. Yu F, Zhu Y, Gong C, et al (2009). Mir-128 regulates the self-renewal of breast tumor-initiating cells through HTERT. Cancer Res, 69, 5157.